ClinVar Miner

Variants in gene combination LAMA4, LOC101927640

See also:
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
0 0 12 16 3 27

Condition and significance breakdown #

Total conditions: 6
Download table as spreadsheet
Condition uncertain significance likely benign benign total
not specified 2 11 2 14
Dilated cardiomyopathy 1JJ 5 3 1 9
Cardiovascular phenotype 2 2 0 4
not provided 3 0 0 3
Dilated cardiomyopathy 1S 0 1 0 1
Familial hypertrophic cardiomyopathy 1 1 0 0 1

Submitter and significance breakdown #

Total submitters: 9
Download table as spreadsheet
Submitter uncertain significance likely benign benign total
GeneDx 1 8 2 11
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine 2 4 1 7
Invitae 4 2 1 7
Ambry Genetics 2 2 0 4
Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen 1 1 0 2
Biesecker Lab/Human Development Section,National Institutes of Health 1 0 0 1
Agnes Ginges Centre for Molecular Cardiology,Centenary Institute 1 0 0 1
Stanford Center for Inherited Cardiovascular Disease,Stanford University 1 0 0 1
Erich and Hanna Klessmann Institute for Cardiovascular Research and Development,Heart and Diabetes Center North Rhine-Westphalia 0 1 0 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.